The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice

• Published in: Mucosal immunology Vol. 7; no. 6; pp. 1416 - 1428
• Main Authors: Jakobsson, T, Vedin, L-L, Hassan, T, Venteclef, N, Greco, D, D'Amato, M, Treuter, E, Gustafsson, J-Å, Steffensen, K R
• Format: Journal Article
• Language: English
• Published: New York Elsevier Inc 01.11.2014; Nature Publishing Group US
• Subjects: 631/250/347; 692/699/1503/1581/1392/1388; 692/699/1503/1581/257; 692/700/565/1436/2185; Allergology; Animals; Antibodies; Biomedical and Life Sciences; Biomedicine; Colitis - chemically induced; Colitis - genetics; Colitis - immunology; Colitis - pathology; Colitis - prevention & control; Colon - immunology; Colon - pathology; Dextran Sulfate - toxicity; Gastroenterology; Immunology; Intestinal Mucosa - immunology; Intestinal Mucosa - pathology; Liver X Receptors; Mice; Mice, Knockout; Orphan Nuclear Receptors - genetics; Orphan Nuclear Receptors - immunology; Trinitrobenzenes - toxicity; Tumor Necrosis Factor-alpha - genetics; Tumor Necrosis Factor-alpha - immunology
• ISSN: 1933-0219; 1935-3456; 1935-3456
• DOI: 10.1038/mi.2014.31

We examined the function of the oxysterol receptors (LXRs) in inflammatory bowel disease (IBD) through studying dextran sodium sulfate (DSS)- and 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice and by elucidating molecular mechanisms underlying their anti-inflammatory action. We observed that Lxr-deficient mice are more susceptible to colitis. Clinical indicators of colitis including weight loss, diarrhea and blood in feces appeared earlier and were more severe in Lxr-deficient mice and particularly LXRβ protected against symptoms of colitis. Addition of an LXR agonist led to faster recovery and increased survival. In contrast, Lxr-deficient mice showed slower recovery and decreased survival. In Lxr-deficient mice, inflammatory cytokines and chemokines were increased together with increased infiltration of immune cells in the colon epithelium. Activation of LXRs strongly suppressed expression of inflammatory mediators including TNFα. While LXRα had anti-inflammatory effects in CD11b+ immune cell populations, LXRβ in addition had anti-inflammatory effects in colon epithelial cells. Lack of LXRβ also induced CD4+/CD3+ immune cell recruitment to the inflamed colon. Expression of both LXRA and LXRB was significantly suppressed in inflamed colon from subjects with IBD compared with non-inflamed colon. Taken together, our observations suggest that the LXRs could provide interesting targets to reduce the inflammatory responses in IBD.